Pyrazoloquinolines as PDE10A inhibitors: Discovery of a tool compoundMCELROY, William T; ZHENG TAN; XIAOPING ZHANG et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 3, pp 1335-1339, issn 0960-894X, 5 p.Article

Intérêt thérapeutique d'un inhibiteur de la phosphodiestérase de type 5 et d'un antagoniste sélectif des récepteurs de l' endothéline AALLANORE, Yannick.La Revue de médecine interne (Paris). 2010, Vol 31, pp 8-9, issn 0248-8663, 2 p., HS1Article

Phosphodiesterase inhibitors block the acceleration of skin permeability barrier repair by red lightGOTO, Makiko; IKEYAMA, Kazuyuki; TSUTSUMI, Moe et al.Experimental dermatology. 2011, Vol 20, Num 7, pp 568-571, issn 0906-6705, 4 p.Article

Role of Growth Factors in Improved Skin Flap Viability Caused by Phosphodiesterase-5 InhibitorBANDERA, Bradley C; PHAM, Thach; HILL-PRYOR, Crystal et al.The American surgeon. 2010, Vol 76, Num 6, pp 614-617, issn 0003-1348, 4 p.Article

Selective phosphodiesterase inhibitors : a promising target for cognition enhancementRENEERKENS, Olga A. H; RUTTEN, Kris; STEINBUSCH, Harry W. M et al.Psychopharmacologia. 2009, Vol 202, Num 1-3, pp 419-443, issn 0033-3158, 25 p.Article

Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitorsPACKARD, Garrick K; PAPA, Patrick; MCCARRICK, Margaret A et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 747-752, issn 0960-894X, 6 p.Article

Biflavones of Decussocarpus rospigliosii as phosphodiesterases inhibitorsCHAABI, Mehdi; ANTHEAUME, Cyril; WENIGET, Bernard et al.Planta medica. 2007, Vol 73, Num 12, pp 1284-1286, issn 0032-0943, 3 p.Article

Is phosphodiesterase type 5 inhibitor use associated with condom breakage? CommentaryCROSBY, R; YARBER, W. L; SANDERS, S. A et al.Sexually transmitted infections. 2009, Vol 85, Num 5, pp 404-406, issn 1368-4973, 3 p.Article

The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokineticsRAWSON, David J; BALLARD, Stephen; FLOC'H, Marion et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 1, pp 498-509, issn 0968-0896, 12 p.Article

Modulation of Morphine-induced Antinociception in Acute and Chronic Opioid Treatment by IbudilastLILIUS, Tuomas O; RAUHALA, Pekka V; KAMBUR, Oleg et al.Anesthesiology (Philadelphia). 2009, Vol 111, Num 6, pp 1356-1364, issn 0003-3022, 9 p.Article

Mind the gap: Delayed manifestation of long-term object memory improvement by phosphodiesterase inhibitorsAKKERMAN, S; BLOKLAND, A; PRICKAERTS, J et al.Neurobiology of learning and memory (Print). 2014, Vol 109, pp 139-143, issn 1074-7427, 5 p.Article

Effects of phosphodiesterase type 5 inhibitors on endothelial function and cardiovascular autonomic nerve function in menSTIRBAN, Alin; TAMLER, Ronald; ANDREI VERESIU, Loan et al.Journal of men's health (Print). 2011, Vol 8, Num 2, pp 109-118, issn 1875-6867, 10 p.Article

Est-il opportun de prescrire des inhibiteurs de la phosphodiestérase pour traiter le prostatisme? : UROLOGIE = Should we prescribe phosphodiesterase inhibitors for the treatment of symptomatic benign prostatic hyperplasiaCAVIEZEL, A; ISELIN, C. E.Revue médicale suisse. 2011, Vol 7, Num 320, pp 2394-2397, issn 1660-9379, 4 p.Article

Phosphodiesterase Inhibitors: Factors That Influence Potency, Selectivity, and ActionFRANCIS, Sharron H; HOUSLAY, Miles D; CONTI, Marco et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 47-84, issn 0171-2004, 38 p.Article

The flavonoid dioclein reduces the production of pro-inflammatory mediators in vitro by inhibiting PDE4 activity and scavenging reactive oxygen speciesGUABIRABA, Rodrigo; CAMPANHA-RODRIGUES, Ana Lucia; SOUZA, Adriano L. S et al.European journal of pharmacology. 2010, Vol 633, Num 1-3, pp 85-92, issn 0014-2999, 8 p.Article

Phosphodiesterase-5 inhibitors and rosacea : report of 10 casesIOANNIDES, D; LAZARIDOU, E; APALLA, Z et al.British journal of dermatology (1951). 2009, Vol 160, Num 3, pp 719-720, issn 0007-0963, 2 p.Article

Nebulized Phosphodiesterase III Inhibitor During Warm Ischemia Attenuates Pulmonary Ischemia-Reperfusion InjuryJITIAN ZHANG; FENGSHI CHEN; DATE, Hiroshi et al.The Journal of heart and lung transplantation. 2009, Vol 28, Num 1, pp 79-84, issn 1053-2498, 6 p.Article

How to optimise treatment of erectile dysfunction above and beyond the beneficial effects of a phosphodiesterase type 5 inhibitorGOOREN, Louis.Journal of men's health. 2008, Vol 5, Num 2, pp 163-170, 8 p.Article

Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+ ) -2 -[4 -({[2 -(benzo[1,3 ]dioxol -5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and humanKALGUTKAR, Amit S; BO FENG; DUIGNAN, David B et al.Drug metabolism and disposition. 2007, Vol 35, Num 11, pp 2111-2118, issn 0090-9556, 8 p.Article

6-Nitrobenzimidazole derivatives: Potential phosphodiesterase inhibitors: Synthesis and structure-activity relationshipKHAN, K. M; SHAH, Zarbad; VOELTER, W et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 4, pp 1521-1526, issn 0968-0896, 6 p.Article

Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophreniaRAHEEM, Izzat T; BRESLIN, Michael J; RENGER, John J et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 18, pp 5903-5908, issn 0960-894X, 6 p.Article

Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignanciesRICKLES, Richard J; PIERCE, Laura T; GIORDANO, Thomas P et al.Blood. 2010, Vol 116, Num 4, pp 593-602, issn 0006-4971, 10 p.Article

Early Events in Vascular Injury in the Rat Induced by the Phosphodiesterase IV Inhibitor SCH 351591WEAVER, James L; JUN ZHANG; KNAPTON, Alan et al.Toxicologic pathology. 2010, Vol 38, Num 5, pp 738-744, issn 0192-6233, 7 p.Article

Effect of a phosphodiesterase type 3 inhibitor in oocyte maturation medium on subsequent mouse embryo developmentBYUNG CHUL JEE; CHEN, Hai-Ying; CHIAN, Ri-Cheng et al.Fertility and sterility. 2009, Vol 91, Num 5, pp 2037-2042, issn 0015-0282, 6 p., SUPArticle

Phosphodiesterase Inhibitors for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?MATERA, Maria Gabriella; ROGLIANI, Paola; CALZETTA, Luigino et al.Drugs (Basel). 2014, Vol 74, Num 17, pp 1983-1992, issn 0012-6667, 10 p.Article